Pobadora, Celso G.

HRN: 22-69-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2023
CEFTRIAXONE 1G (VIAL)
03/03/2023
03/10/2023
IV
2gms
OD
CAP MR
Waiting Final Action 
03/03/2023
AZITHROMYCIN 500MG TABLET (TAB)
03/03/2023
03/08/2023
PO
500mg
OD
CAP MR
Waiting Final Action 
03/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/07/2023
03/21/2023
IV
4.5g
Q6
CAP HR
Waiting Final Action 
03/23/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
03/23/2023
03/29/2023
IVT
750mg
OD
Pneumonia
Waiting Final Action 
03/27/2023
MUPIROCIN 2%, 15G (TUBE)
03/27/2023
04/03/2023
TOPICAL
2%
BID
Soft Tissue Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: